DCM
TRIB

Delpha Capital Management’s Trinity Biotech TRIB Stock Holding History

Delpha Capital Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1
Closed -$1K – 1126
2017
Q4 		$1K Buy
+1
New +$773 ﹤0.01% 1594

Other funds holding TRIB

Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

Delpha Capital Management's TRIB Position: Q1 2018 in Review

Delpha Capital Management sold out of Trinity Biotech (TRIB) in Q1 2018, closing a stake of 1 share — an estimated $1K sold.

Delpha Capital Management first reported a position in TRIB in Q4 2017 and held it in 1 quarter. The position peaked at $1K in Q4 2017. 44 funds tracked by Wall St. Rank hold TRIB as of Q1 2018.

  • Delpha Capital Management reported no remaining Trinity Biotech position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 1 Trinity Biotech share in Q1 2018, an estimated $1K.
  • Delpha Capital Management first reported a position in Trinity Biotech in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Trinity Biotech position peaked at $1K in Q4 2017.
  • 44 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.